Click to view this message in a browserPharmiWeb Solutions Newsletter
Welcome to the latest update from
sponsors banner

Dear {FIRST_NAME|Colleague},
Latest news and update from #114

Novartis To Restructure Its Us Businessseperator13 January 2012
seperator13 January 2012
NICE Unable To Endorse New Treatment For Prostate Cancerseperator12 January 2012
Almac Strengthens Board With Appointment Of New Financial Directorseperator11 January 2012
Skyepharma Plc – Reorganisation Of Swiss Operationsseperator10 January 2012

Business Associate, Cell Therapy & Regenerative Medicine – UK & IrelandseperatorSurrey , England
Business Associate, Cell Therapy & Regenerative MedicineseperatorUK
Director Of Regulatory, Pharmacovigilance And MedicalseperatorSouth West - Barnstaple, UK
Quality Manager - PharmaceuticalsseperatorCheshire UK

Option Suisse *** Regulatory Affairs International – Regional Regulatory Managers –facilitate And Support Clusters Of Affiliates Latam, Ap Or CeeseperatorOption Suisse - Switzerland - Relocation Provided 
Oncology Portfolio ManagerseperatorUnited Kingdom - England Hertfordshire 
Clinical Project Manager To Associate Director (various) – EuropeseperatorVarious Across Europe 
Quality Manager - PharmaceuticalsseperatorCheshire Uk 
Option Suisse *** Regulatory Affairs International – Ra Project Manager For Brickm R And T (major Internationals) – International Phase 3 Ctas And MaaseperatorOption Suisse - Switzerland - Relocation Provided 
(novartis) Quality Assurance Director/cpo Quality Unit HeadseperatorFrimley, Surrey, Gu16 &sr 
Qa/senior QA Auditor - Medical Devices (switzerland)seperatorUk Or Switzerland 

Research And Markets: Estonia Pharmaceuticals And Healthcare Report Q1 2012seperatorResearch and Markets
13 January 2012Business Wire
Rbcc Enters New World Of OpportunityseperatorRainbow Coral Corp.
13 January 2012Business Wire
Seattle Genetics Announces Updates To Adcetris™ Prescribing InformationseperatorSeattle Genetics Inc.
13 January 2012Business Wire
Novartis To Restructure Us Business To Strengthen Competitive Position In Light Of Loss Of Diovan® Patent And Announces Charge For Rasilez®/tekturna®seperatorNovartis
13 January 2012Novartis
Covance, Inserm Transfert Sa, And Inserm Transfert Initiative Enter Four-Year Scientific AgreementseperatorCovance Inc
13 January 2012Covance Inc

Top Ten Talent Issues For 2012seperatorKathy Lou Marketing Manager, China HAYS Recruiting expert worldwide
21 December 2011
Asia Pacific - A Resourcing PerspectiveseperatorPaula Mumby, Vice President, Operations, Asia Pacific
21 December 2011
The End Of The Sick Note..?seperatorDavid Blomfield
09 December 2011
What’s In It For You? Employers Put The Focus Back On Candidates Trying To Find Their Career PathseperatorHAYS
05 December 2011
The Challenges Of PharmacovigilanceseperatorABBYY
23 November 2011

 Recruitment | Health Economics | Marketing | Sales | CRA | Medical Writing | Executive Pharma
Netherlands | Belgium | France | Germany | Switzerland | Ireland | Scotland | Wales | USA |
 PharmiWeb on Facebook PharmiWeb News on Twitter PharmiWeb on Twitter PharmiWeb on LinkedIn PharmiWeb on RSS  
Email base top

PharmiWeb Solutions - Building Online Communities in Healthcare
For editorial enquiries regarding this newsletter, please contact , call: +44 (0) 1344 667448 or contact

Please note: we are not responsible for content that is external to our site, submitted to us by our contributors or outside our direct control.

Email base bottom